Valtoco Nasal Spray: Usage, Warnings, Side Effects - Drugs.com
...Valtoco (diazepam nasal spray) is a federally controlled substance (C-IV) because it can be abused or lead to dependence. Keep this medicine in a safe place to prevent misuse and abuse....
https://www.drugs.com/valtoco.html
Frequently Asked Questions | VALTOCO® (diazepam nasal spray)
...VALTOCO is a prescription medicine used for short-term treatment of seizure clusters (also known as ?episodes of frequent seizure activity? or ?acute repetitive seizures?) that are different from a person?s normal seizure pattern in people 2 years of age and older. VALTOCO is a federally controlled substance (CIV) because it can be abused or lead to dependence. Keep VALTOCO in a safe ......
https://valtoco.com/about-valtoco/frequently-asked-questions/
Safety | VALTOCO® (diazepam nasal spray) CIV - valtocohcp.com
...Review clinical trial safety data, potential side effects, drug interactions, and warnings and precautions for VALTOCO when prescribing as an immediate-use seizure medication. Please see full Prescribing Information, including Boxed Warning, and Instructions for Use....
https://www.valtocohcp.com/safety/
Valtoco (diazepam): Uses, Side Effects, Dosage & Reviews - GoodRx
...Valtoco (diazepam) is a prescription medication that's used for short-term treatment of seizures in adults and children 2 years of age and older. It comes as a ready-to-use nasal spray device, but the person giving the medication must know when and how to give it correctly. Common side effects of Valtoco (diazepam) include feeling sleepy, headache, and nasal discomfort....
https://www.goodrx.com/valtoco/what-is
FDA Expands Diazepam Nasal Spray Indication to Treat Ages 2 to 5
...Recent studies confirm Valtoco's safety and efficacy across age groups, with age-related differences in seizure type and treatment response. Valtoco remains a Schedule IV controlled substance due to potential abuse risks, with contraindications for certain conditions and possible nasal side effects. SHOW MORE...
https://www.neurologylive.com/view/fda-expands-diazepam-nasal-spray-indication-treat-ages-2-to-5